A real‐world observational cohort of patients with primary biliary cholangitis: TARGET‐primary biliary cholangitis study design and rationale

Primary biliary cholangitis (PBC) is a rare chronic cholestatic liver disease that may progress to biliary cirrhosis if left untreated. The first‐line therapy for PBC is ursodeoxycholic acid (UDCA). Unfortunately, 1 of 3 patients does not respond to UDCA. These patients are at risk for developing cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Levy, Cynthia, Bowlus, Christopher L., Carey, Elizabeth, Crawford, Julie M., Deane, Karen, Mayo, Marlyn J., Kim, W. Ray, Fried, Michael W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944592/
https://www.ncbi.nlm.nih.gov/pubmed/29761165
http://dx.doi.org/10.1002/hep4.1173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944592/
https://www.ncbi.nlm.nih.gov/pubmed/29761165
http://dx.doi.org/10.1002/hep4.1173

Ejemplares similares